UGT3A2 | UDP glycosyltransferase 3 family, polypeptide A2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LMBRD2 | LMBR1 domain containing 2 | Predicted membrane proteins
| | | | | Expressed in all |
SKP2 | S-phase kinase-associated protein 2, E3 ubiquitin protein ligase | Cancer-related genes
| | | | | Expressed in all |
NADK2 | NAD kinase 2, mitochondrial | Enzymes
| | | | | Tissue enriched |
RANBP3L | RAN binding protein 3-like | | | | | | Tissue enhanced |
SLC1A3 | Solute carrier family 1 (glial high affinity glutamate transporter), member 3 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
NIPBL | Nipped-B homolog (Drosophila) | Disease related genes Plasma proteins
| | | | | Expressed in all |
C5orf42 | Chromosome 5 open reading frame 42 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
NUP155 | Nucleoporin 155kDa | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
WDR70 | WD repeat domain 70 | | | | | | Expressed in all |
GDNF | Glial cell derived neurotrophic factor | Cancer-related genes Disease related genes Predicted secreted proteins
| | | | | Mixed |
EGFLAM | EGF-like, fibronectin type III and laminin G domains | Predicted secreted proteins
| | | | | Mixed |
LIFR | Leukemia inhibitory factor receptor alpha | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
OSMR | Oncostatin M receptor | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
RICTOR | RPTOR independent companion of MTOR, complex 2 | | | | | | Expressed in all |
FYB | FYN binding protein | | | | | | Tissue enhanced |
AC008964.1 | | | | | | | Tissue enhanced |
C9 | Complement component 9 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
DAB2 | Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) | Plasma proteins
| | | | | Expressed in all |
PTGER4 | Prostaglandin E receptor 4 (subtype EP4) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
TTC33 | Tetratricopeptide repeat domain 33 | | | | | | Expressed in all |
PRKAA1 | Protein kinase, AMP-activated, alpha 1 catalytic subunit | Enzymes FDA approved drug targets
| | | | | Expressed in all |
RPL37 | Ribosomal protein L37 | Ribosomal proteins
| | | | | Expressed in all |
CARD6 | Caspase recruitment domain family, member 6 | Plasma proteins
| | | | | Mixed |
C7 | Complement component 7 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MROH2B | Maestro heat-like repeat family member 2B | | | | | | Tissue enriched |
C6 | Complement component 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
PLCXD3 | Phosphatidylinositol-specific phospholipase C, X domain containing 3 | | | | | | Tissue enhanced |
OXCT1 | 3-oxoacid CoA transferase 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
C5orf51 | Chromosome 5 open reading frame 51 | | | | | | Expressed in all |
FBXO4 | F-box protein 4 | | | | | | Expressed in all |
GHR | Growth hormone receptor | Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CCDC152 | Coiled-coil domain containing 152 | | | | | | Mixed |
SEPP1 | Selenoprotein P, plasma, 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ANXA2R | Annexin A2 receptor | | | | | | Tissue enhanced |
ZNF131 | Zinc finger protein 131 | Transcription factors
| | | | | Expressed in all |
NIM1K | NIM1 serine/threonine protein kinase | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
HMGCS1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) | Enzymes Plasma proteins
| | | | | Expressed in all |
CCL28 | Chemokine (C-C motif) ligand 28 | Predicted secreted proteins
| | | | | Tissue enriched |
C5orf28 | Chromosome 5 open reading frame 28 | Predicted membrane proteins
| | | | | Expressed in all |
C5orf34 | Chromosome 5 open reading frame 34 | | | | | | Mixed |
PAIP1 | Poly(A) binding protein interacting protein 1 | | | | | | Expressed in all |
NNT | Nicotinamide nucleotide transhydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
FGF10 | Fibroblast growth factor 10 | Disease related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
MRPS30 | Mitochondrial ribosomal protein S30 | Mitochondrial proteins Ribosomal proteins
| | | | | Expressed in all |
HCN1 | Hyperpolarization activated cyclic nucleotide-gated potassium channel 1 | Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
EMB | Embigin | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
PARP8 | Poly (ADP-ribose) polymerase family, member 8 | Enzymes
| | | | | Mixed |
ISL1 | ISL LIM homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
CTD-2203A3.1 | Uncharacterized protein | | | | | | Not detected |